Abeona Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Abeona Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Abeona Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Abeona Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Abeona Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2023205626A3 | Application | Compositions and methods for treating dominant optic atrophy and x-linked retinoschisis | C12N15/86; C12N2750/14143; C12N2830/008; C12N2830/42; C12N2830/50; A61K38/00; A61K48/0041; A61K48/005; A61K48/0058; A61K48/0075 | November 30, 2023 |
| WO2023205626A2 | Application | Compositions and methods for treating dominant optic atrophy and x-linked retinoschisis | C12N15/86; C12N2750/14143; C12N2830/008; C12N2830/42; C12N2830/50; A61K38/00; A61K48/0041; A61K48/005; A61K48/0058; A61K48/0075 | October 26, 2023 |
| US20230287458A1 | Application | Recombinant adeno-associated viral vectors for multipartite gene delivery | C12N15/85; C12N15/86; C12N15/907; C12N2750/14143; C12N2800/30; C12N9/1241 | September 14, 2023 |
| EP4182467A1 | Application | Rekombinante adeno-assoziierte virale vektoren zur multilateralen genverabreichung | C12N15/85; C12N15/86; C12N15/907; C12N2750/14143; C12N2800/30; C12N9/1241 | May 24, 2023 |
| CA3216533A1 | Application | Methods and compositions for treating ocular diseases and disorders | C12N2750/14122; C12N2750/14143; C12N2750/14145; A61K35/76; A61K48/005; A61K48/0075; A61P27/02; C07K14/005 | November 24, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer